

Phase 2 Clinical Trial for CMT1 and CMTX
Acceleron recruited adults with CMT1 and CMTX for a Phase 2 clinical trial studying investigational drug ACE-083.
Thank you for your interest in participating, but the study is fully subscribed and registration is closed.

